WST Valuation

West Pharmaceutical Services Inc

Add to Watchlist

Advanced Chart

203.530

+13.140(+6.900%)

Overview
Forecast
Valuation

WST Relative Valuation

WST's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, WST is overvalued; if below, it's undervalued.

Historical Valuation

West Pharmaceutical Services Inc (WST) is now in the Undervalued zone, suggesting that its current forward PE ratio of 30.90 is considered Undervalued compared with the five-year average of 45.60. The fair price of West Pharmaceutical Services Inc (WST) is between 233.20 to 323.57 according to relative valuation methord. Compared to the current price of 203.53 USD , West Pharmaceutical Services Inc is Undervalued By 12.72%.

Relative Value

Fair Zone

233.20-323.57

Current Price：203.53

12.72%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

5.16

P/B

Median3y

8.88

Median5y

10.41

2.01

FCF Yield

Median3y

1.65

Median5y

1.50

Competitors Valuation Multiple

The average P/S ratio for WST's competitors is 4.50, providing a benchmark for relative valuation. West Pharmaceutical Services Inc Corp (WST) exhibits a P/S ratio of 4.75, which is 5.49% above the industry average. Given its robust revenue growth of 2.30%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

WST.N

West Pharmaceutical Services Inc